Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP580616.RAbmJ4YesEgPOQBM2LW7ivBS8rzLb9cv2Hgv_5l8m3nso130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP580616.RAbmJ4YesEgPOQBM2LW7ivBS8rzLb9cv2Hgv_5l8m3nso130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP580616.RAbmJ4YesEgPOQBM2LW7ivBS8rzLb9cv2Hgv_5l8m3nso130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP580616.RAbmJ4YesEgPOQBM2LW7ivBS8rzLb9cv2Hgv_5l8m3nso130_provenance.
- NP580616.RAbmJ4YesEgPOQBM2LW7ivBS8rzLb9cv2Hgv_5l8m3nso130_assertion description "[These results indicate that the c-myb gene in human colon cancer is one of the factors related to cisplatin resistance, and support the need to develop anti-cancer therapeutics based on oncogene-targeted antisense oligonucleotide technology.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP580616.RAbmJ4YesEgPOQBM2LW7ivBS8rzLb9cv2Hgv_5l8m3nso130_provenance.
- NP580616.RAbmJ4YesEgPOQBM2LW7ivBS8rzLb9cv2Hgv_5l8m3nso130_assertion evidence source_evidence_literature NP580616.RAbmJ4YesEgPOQBM2LW7ivBS8rzLb9cv2Hgv_5l8m3nso130_provenance.
- NP580616.RAbmJ4YesEgPOQBM2LW7ivBS8rzLb9cv2Hgv_5l8m3nso130_assertion SIO_000772 11410788 NP580616.RAbmJ4YesEgPOQBM2LW7ivBS8rzLb9cv2Hgv_5l8m3nso130_provenance.
- NP580616.RAbmJ4YesEgPOQBM2LW7ivBS8rzLb9cv2Hgv_5l8m3nso130_assertion wasDerivedFrom befree-20150227 NP580616.RAbmJ4YesEgPOQBM2LW7ivBS8rzLb9cv2Hgv_5l8m3nso130_provenance.
- NP580616.RAbmJ4YesEgPOQBM2LW7ivBS8rzLb9cv2Hgv_5l8m3nso130_assertion wasGeneratedBy ECO_0000203 NP580616.RAbmJ4YesEgPOQBM2LW7ivBS8rzLb9cv2Hgv_5l8m3nso130_provenance.
- befree-20150227 importedOn "2015-02-27" NP580616.RAbmJ4YesEgPOQBM2LW7ivBS8rzLb9cv2Hgv_5l8m3nso130_provenance.